Mismatched Imaging Findings of Prostate Cancer Diagnosis:68 Ga-PSMA PET/CT vs mpMRI / 대한핵의학회잡지
Korean Journal of Nuclear Medicine
; : 199-202, 2021.
Article
in En
| WPRIM
| ID: wpr-997531
Responsible library:
WPRO
ABSTRACT
Multiparametric magnetic resonance imaging (mpMRI) is the modality of choice for initial diagnosis of prostate cancer (PCa), including biopsy-naïve patients. Nevertheless, clinicians must be aware of the possibility that up to one-fourth of clinically significant cancers might be missed by the modality. Acknowledgment of this occurrence and the increased availability of 68 Ga-PSMA PET/CT in clinical routine, open the door to new, fascinating, indications for this functional modality in the context of PCa detection. With the case herein illustrated, we report a paradigmatic example of mismatch findings between PET/CT and mpMRI better elucidating the potential indication.
Full text:
1
Database:
WPRIM
Language:
En
Journal:
Korean Journal of Nuclear Medicine
Year:
2021
Document type:
Article